公开(公告)号：US20230023185A1

公开(公告)日：2023-01-26

申请号：US17945043

申请日：2022-09-14

申请人： Edgar Lee Hull, JR.

发明人： Edgar Lee Hull, JR. ,  Narashima Murthy ,  Sridhara Am

IPC分类号： A61K38/44 ,  A61K31/405 ,  A61K33/04 ,  A61K31/51 ,  A61K31/525 ,  A61K31/455 ,  A61K31/4415 ,  A61K31/519 ,  A61K31/714 ,  A61K31/197 ,  A61K31/355 ,  A61K31/122 ,  A61K33/00 ,  A61K31/198 ,  A61K31/4172 ,  A61K33/30

摘要： A low nitrogen protein food composition Albutrix™ for use by kidney patients in Stages 3, 4, 4a, 4b, and 5, who are not on dialysis, in a treatment program comprising administering daily a: low nitrogen diet; low nitrogen protein food comprising magnesium and/or calcium salts of alpha keto acids; and time released vitamin. The vitamin comprises the active ingredients of: Zinc; Selenium; Vitamins B1, B2, B6, B12, B5, E, and K2; Niacin; superoxide dismutase; catalase; glutathione and Folate; and excludes calcium, magnesium, phosphorus, sodium, manganese, fluoride, Vitamin D and K1. The low nitrogen food contains daily up to 300 mg of nitrogen; and at least five alpha keto analogues of magnesium and/or calcium salts of: leucine, isoleucine, methionine (MEMS-II), phenylalanine (PAMS-I), and valine. The treatment results in an increase of Glomerular Filtration Rate (GFR), a decrease in blood urea levels, and a decrease in creatinine levels.

公开(公告)号：US12109254B2

公开(公告)日：2024-10-08

申请号：US17945043

申请日：2022-09-14

申请人： Edgar Lee Hull, Jr.

发明人： Edgar Lee Hull, Jr. ,  Narashima Murthy ,  Sridhara Am

IPC分类号： A61K38/44 ,  A61K31/122 ,  A61K31/197 ,  A61K31/198 ,  A61K31/355 ,  A61K31/405 ,  A61K31/4172 ,  A61K31/4415 ,  A61K31/455 ,  A61K31/51 ,  A61K31/519 ,  A61K31/525 ,  A61K31/714 ,  A61K33/00 ,  A61K33/04 ,  A61K33/30

CPC分类号： A61K38/443 ,  A61K31/122 ,  A61K31/197 ,  A61K31/198 ,  A61K31/355 ,  A61K31/405 ,  A61K31/4172 ,  A61K31/4415 ,  A61K31/455 ,  A61K31/51 ,  A61K31/519 ,  A61K31/525 ,  A61K31/714 ,  A61K33/00 ,  A61K33/04 ,  A61K33/30 ,  A61K38/446

摘要： A low nitrogen protein food composition Albutrix™ for use by kidney patients in Stages 3, 4, 4a, 4b, and 5, who are not on dialysis, in a treatment program comprising administering daily a: low nitrogen diet; low nitrogen protein food comprising magnesium and/or calcium salts of alpha keto acids; and time released vitamin. The vitamin comprises the active ingredients of: Zinc; Selenium; Vitamins B1, B2, B6, B12, B5, E, and K2; Niacin; superoxide dismutase; catalase; glutathione and Folate; and excludes calcium, magnesium, phosphorus, sodium, manganese, fluoride, Vitamin D and K1. The low nitrogen food contains daily up to 300 mg of nitrogen; and at least five alpha keto analogues of magnesium and/or calcium salts of: leucine, isoleucine, methionine (MEMS-II), phenylalanine (PAMS-I), and valine. The treatment results in an increase of Glomerular Filtration Rate (GFR), a decrease in blood urea levels, and a decrease in creatinine levels.